The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Pathophysiology of Nonalcoholic Steatohepatitis
Open accessAbstract
Nonalcoholic steatohepatitis (NASH), occurs frequently with diabetes mellitus and obesity, contributes to insulin resistance, can develop cirrhosis or even hepatocellular carcinoma (HCC). Although NASH has become more common, its underlying mechanism is still not clear and effective therapy has not been established. Currently, it has been recognized that the multiple parallel factors, including genetic differences, insulin resistance, lipotoxicity and dysbiosis act synergistically in genetically in pathogenesis of NASH. Impaired autophagy parallel to excess lipid supply might explain the progression of NASH to HCC. Liver-specific knockout mice of phosphatase and tensin homolog deleted on chromosome ten (PTEN) develops steatohepatitis followed by HCC, suggesting a potential role for this molecule in development and progression of NASH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
Ludwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
Tilg, H., & Moschen, A. R. (2010) · Hepatology · doi:10.1002/hep.24001 · Cited by 2,548
Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas
Horie, Y., Suzuki, A., Kataoka, E., Sasaki, T., Hamada, K., Sasaki, J., Mizuno, K., Hasegawa, G., Kishimoto, H., Iizuka, M., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420513 · Cited by 698
Self-citationPersistent activation of Nrf2 through p62 in hepatocellular carcinoma cells
Inami, Y., Waguri, S., Sakamoto, A., Kouno, T., Nakada, K., Hino, O., Watanabe, S., Ando, J., Iwadate, M., Yamamoto, M., et al. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201102031 · Cited by 604
Self-citationImajo, K., Fujita, K., Yoneda, M., Nozaki, Y., Ogawa, Y., Shinohara, Y., Kato, S., Mawatari, H., Shibata, W., Kitani, H., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.05.012 · Cited by 341
Self-citationWatanabe, S., Hashimoto, E., Ikejima, K., Uto, H., Ono, M., Sumida, Y., Seike, M., Takei, Y., Takehara, T., Tokushige, K., et al. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1050-7 · Cited by 327
Self-citationKabbany, M. N., Selvakumar, P. K. C., Watt, K., Lopez, R., Akras, Z., Zein, N., Carey, W., & Alkhouri, N. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2017.5 · Cited by 242
Watanabe, S., Hashimoto, E., Ikejima, K., Uto, H., Ono, M., Sumida, Y., Seike, M., Takei, Y., Takehara, T., Tokushige, K., et al. (2015) · Hepatology Research · doi:10.1111/hepr.12511 · Cited by 200
Self-citationFukuo, Y., Yamashina, S., Sonoue, H., Arakawa, A., Nakadera, E., Aoyama, T., Uchiyama, A., Kon, K., Ikejima, K., & Watanabe, S. (2014) · Hepatology Research · doi:10.1111/hepr.12282 · Cited by 192
Self-citationLiver diseases and metabolic syndrome
Watanabe, S., Yaginuma, R., Ikejima, K., & Miyazaki, A. (2008) · Journal of Gastroenterology · doi:10.1007/s00535-008-2193-6 · Cited by 175
Self-citationInami, Y., Yamashina, S., Izumi, K., Ueno, T., Tanida, I., Ikejima, K., & Watanabe, S. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.08.012 · Cited by 152
Self-citationRole of adipocytokines in hepatic fibrogenesis
Ikejima, K., Okumura, K., Kon, K., Takei, Y., & Sato, N. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04961.x · Cited by 98
CD1d-restricted natural killer T cells contribute to hepatic inflammation and fibrogenesis in mice
Ishikawa, S., Ikejima, K., Yamagata, H., Aoyama, T., Kon, K., Arai, K., Takeda, K., & Watanabe, S. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.022 · Cited by 63
Self-citationHosoya, S., Ikejima, K., Takeda, K., Arai, K., Ishikawa, S., Yamagata, H., Aoyama, T., Kon, K., Yamashina, S., & Watanabe, S. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00083.2012 · Cited by 38
Self-citationTakashima, S., Ikejima, K., Arai, K., Yokokawa, J., Kon, K., Yamashina, S., & Watanabe, S. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00465.2015 · Cited by 30
Self-citationLeptin-to-adiponectin ratio in obese adolescents with nonalcoholic fatty liver disease
Angın, Y., Arslan, N., & Kuralay, F. (2014) · The Turkish Journal of Pediatrics · doi:10.24953/turkjpediatr.2014.1361 · Cited by 20
Morinaga, M., Kon, K., Saito, H., Arai, K., Kusama, H., Uchiyama, A., Yamashina, S., Ikejima, K., & Watanabe, S. (2015) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.15-75 · Cited by 15
Self-citationL‐carnitine prevents metabolic steatohepatitis in obese diabetic KK‐Ay mice
Kon, K., Ikejima, K., Morinaga, M., Kusama, H., Arai, K., Aoyama, T., Uchiyama, A., Yamashina, S., & Watanabe, S. (2016) · Hepatology Research · doi:10.1111/hepr.12720 · Cited by 14
Self-citation
Cited by
Williams, C. D., Stengel, J., Asike, M. I., Torres, D. M., Shaw, J., Contreras, M., Landt, C. L., & Harrison, S. A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.09.038 · Cited by 2,148
Non-alcoholic fatty liver disease and increased risk of cardiovascular disease
Targher, G., & Arcaro, G. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.08.021 · Cited by 551
Kupffer cells in non-alcoholic fatty liver disease: The emerging view
Baffy, G. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.03.008 · Cited by 473
Bruce, K. D., Cagampang, F. R., Argenton, M., Zhang, J., Ethirajan, P. L., Burdge, G. C., Bateman, A. C., Clough, G. F., Poston, L., Hanson, M. A., et al. (2009) · Hepatology · doi:10.1002/hep.23205 · Cited by 449
Zivkovic, A. M., German, J. B., & Sanyal, A. J. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.2.285 · Cited by 422
Metadata
- Authors
- WATANABE, S.
- Venue
- Juntendo Medical Journal
- Publisher
- The Jutendo Medical Journal
- Published
- 2017
- Volume
- 63
- Issue
- 4
- Pages
- 230-237
- ISSN
- 0022-6769 (ISSN-L)
- 2187-9737
- 2188-2126
- OpenAlex
- W2757589498
- Cited by
- 257
- References
- 19
- FWCI
- 8.16
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.